Gene: COL11A2
Official Full Name: collagen type XI alpha 2 chainprovided by HGNC
Gene Summary: This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38471 | COL11A2 Knockout cell line (HCT 116) | Human | COL11A2 | 1:2~1:4 | Negative | Online Inquiry |
COL11A2 Gene Knockout Cell Lines are genetically modified cell lines designed to lack the essential COL11A2 gene, which encodes type XI collagen, a critical extracellular matrix protein involved in maintaining tissue structure and integrity. These cell lines serve as powerful tools for investigating the gene's role in various biological processes, including cartilage formation, development, and disorders associated with collagen dysregulation.
The key function of these knockout cell lines lies in their ability to facilitate studies that elucidate the mechanisms of COL11A2's involvement in collagen synthesis and organization within the extracellular matrix. By comparing the cellular behavior of COL11A2 knockout lines with their wild-type counterparts, researchers can assess the impacts of this gene on cellular proliferation, migration, and differentiation. Furthermore, these models enable the exploration of potential therapeutic targets for diseases such as osteoarthritis, where type XI collagen's role is critically involved.
The scientific importance of COL11A2 Gene Knockout Cell Lines extends to both fundamental research and clinical applications. They can be used to study the molecular pathways underlying skeletal disorders, helping to identify biomarkers for disease progression and potential pharmacological interventions. Their use contributes to understanding developmental biology, tissue engineering, and regenerative medicine.
Compared to alternative models, such as transient knockdown systems, these cell lines provide a stable and reproducible genetic background, significantly reducing variability in experimental outcomes. This enhances the reliability and validity of research findings, making them invaluable for both academic and clinical laboratories.
For researchers and clinicians, leveraging COL11A2 Gene Knockout Cell Lines accelerates the discovery of new treatment strategies and insights into collagen-related diseases, ultimately enhancing translational research efforts. Our company's expertise in generating high-quality, precise genetic modifications ensures that these cell lines meet rigorous scientific standards and are readily available to support your research objectives.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.